Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Meningeal Neoplasms × mafosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Lymphoma 1 Leukemia 1 Central Nervous System Neoplasms 1

Interventions

Nivolumab 2 sapanisertib 1 mafosfamide 1 fludarabine 1 avelumab 1 WP 744 1 Topotecan 1 Temozolomide 1 Spinal Puncture 1 Specimen Handling 1 Radiotherapy 1 Magnetic Resonance Spectroscopy 1 Cyclophosphamide 1 Afatinib 1 AZD1390 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00001251 2013-08-19

Phase I Study of Intrathecal Mafosfamide

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡